A transcriptional signature detects homologous recombination deficiency in pancreatic cancer at the individual level-Reference-Cited by-同舟云学术

A transcriptional signature detects homologous recombination deficiency in pancreatic cancer at the individual level

Published:2021-12 Issue: Volume:26 Page:1014-1026
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Zhuang Shuping,Chen Tingting,Li Yawei,Wang Yuquan^ORCID,Ai Liqiang^ORCID,Geng Yiding,Zou Min,Liu Kaidong,Xu Huanhuan^ORCID,Wang Linzhu^ORCID,Zhao Zhangxiang^ORCID,Chang Zhiqiang,Gu Yunyan^ORCID

Funder

Postdoctoral Scientific Research Development Fund of Heilongjiang Province

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference41 articles.

1. Childhood and adolescent cancer statistics, 2014;Ward;CA Cancer J. Clin.,2014

2. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages;Gillen;PLoS Med.,2010

3. Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology;Tempero;J. Natl. Compr. Canc. Netw.,2021

4. Poly(ADP-ribose) polymerase inhibition in pancreatic cancer;Singh;Genes Chromosomes Cancer,2021

5. Genomic features and classification of homologous recombination deficient pancreatic ductal adenocarcinoma;Golan;Gastroenterology,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The coexistence of a BRCA2 germline and a DICER1 somatic variant in two first-degree cousins suggests their potential synergic effect;Scientific Reports;2024-09-13

2. Multiomics analysis of homologous recombination deficiency across cancer types;Biomolecules and Biomedicine;2024-07-28

3. Homologous Recombination Deficiency Detection Algorithms: A Systematic Review;Cancers;2023-11-29

4. Retrospective study of transcriptomic profiling identifies Thai triple-negative breast cancer patients who may benefit from immune checkpoint and PARP inhibitors;PeerJ;2023-06-12

5. Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma;EMBO Molecular Medicine;2023-02-13